Charles River Laboratories International Inc reports results for the quarter ended March 31 - Earnings Summary

Charles River Laboratories International

07/05/2025 14:31

Charles River Laboratories International Inc CRL.N reported quarterly adjusted earnings of $2.34​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of $2.27.  The mean expectation of fifteen analysts for the quarter was for earnings of $2.08 per share. Wall Street expected results to range from $2.00  to $2.27 per share.

Revenue fell 2.7% to $984.17 million from a year ago; analysts expected $941.97 million.

Charles River Laboratories International Inc's reported EPS for the quarter was 50 cents​.

The company reported quarterly net income of $25.47 million.

Charles River Laboratories International Inc shares had fallen by 23.3% this quarter and lost 37.5% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 7.6% in the last three months.​

In the last 30 days, four analysts negatively revised earnings estimates

RECOMMENDATIONS

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 17 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "hold"

Wall Street's median 12-month price target for Charles River Laboratories International Inc is $150.00

This summary was machine generated from LSEG data May 7 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Mar. 31 2025
2.08
2.34
Beat
Dec. 31 2024
2.53
2.66
Beat
Sep. 30 2024
2.43
2.59
Beat
Jun. 30 2024
2.39
2.80
Beat